Research Xspray’s Dasynoc approval bid foiled again by FDA’s manufacturer concernsBy Healthcare Propulsion StaffAugust 20, 20260 Less than a year after the FDA turned down the resubmitted application for the company’s leukemia prospect Dasynoc, Xspray Pharma…
